Skip to main content
. 2017 Jul 4;7:1–8. doi: 10.1016/j.bonr.2017.07.001

Fig. 1.

Fig. 1

Overview of the two study designs. In the prevention study, insulin was administered via CSII at escalating doses early in T1D duration. Non-diabetic and diabetic mice were age-matched to the mice receiving the insulin pumps in order to establish the effect of diabetes on bone. In the rescue study, insulin therapy did not commence until 6 weeks after the first STZ injection (arrows).